Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$11,894,748
+$1,921,682 QoQ
Shares Held
9,917
-8.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.65%
of 13F equity value
Holder Rank
#1,159
of 4,605 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Longbow Finance SA holds $30,871,707 across 4 Drug Manufacturers - General names. LLY ranks #1 (38.5% of the industry book) .
All Filings in LLY
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,894,748 | 9,917 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $9,973,066 | 10,843 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $7,975,201 | 7,421 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $10,160,108 | 13,316 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $14,774,432 | 18,953 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $25,333,963 | 30,674 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $14,091,316 | 18,253 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $15,405,610 | 17,389 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $21,617,758 | 23,877 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $19,608,481 | 25,205 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $8,477,405 | 14,543 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $9,316,519 | 17,345 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,162,127 | 17,404 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||